» Articles » PMID: 28250900

Clinical Utility of 0.025-inch Guidewire VisiGlide2 in the Endoscopic Retrograde Cholangiopancreatography-related Procedures

Overview
Date 2017 Mar 3
PMID 28250900
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To examine the result of the use of 0.025-inch guidewire (GW) VisiGlide2 as the first choice in the endoscopic retrograde cholangiopancreatography (ERCP)-related procedures without selecting the patient in a multicenter prospective study.

Methods: ERCP using 0.025-inch GW VisiGlide2 as the first choice was conducted in patients who have needed ERCP, and its accomplishment rate of procedure, procedural time, incidence of accidental symptoms were compared with those of ERCP using 0.025-inch GW VisiGlide.

Results: The accomplishment rate of procedure was 97.5% (197/202), and procedural time was 23.930 ± 16.207 min. The accomplishment rate of procedure using 0.025-inch GW VisiGlide was 92.3% (183/195), and procedural time was 31.285 ± 19.122 min, thus the accomplishment rate of procedure was significantly improved and procedural time was significantly shortened ( < 0.05). Accidental symptoms by ERCP-related procedures were observed in 3.0% (6/202), and all were conservatively alleviated.

Conclusion: When 0.025-inch GW VisiGlide2 was used for ERCP-related procedure as the first choice, it showed high accomplishment rate of procedure and low incidence of accidental symptoms, suggesting it can be used as the universal GW. Clinical Trial Registry (UMIN0000016042).

Citing Articles

Structural factors influencing the clinical performance of 0.025-inch guidewires for pancreatobiliary endoscopy: An experimental study.

Koga T, Tsuchiya N, Ishida Y, Kitaguchi T, Matsumoto K, Fukuyama M Endosc Int Open. 2024; 12(5):E666-E675.

PMID: 38707594 PMC: 11068439. DOI: 10.1055/a-2290-0363.


Efficacy of a newly developed guidewire for selective biliary access.

Park D, Han J, Lee T, Yang J, Lee J, Lee Y Sci Rep. 2023; 13(1):7637.

PMID: 37169945 PMC: 10175558. DOI: 10.1038/s41598-023-34846-w.


How to perform EUS-guided biliary drainage.

Dietrich C, Braden B, Burmeister S, Aabakken L, Arciadacono P, Bhutani M Endosc Ultrasound. 2022; 11(5):342-354.

PMID: 36255022 PMC: 9688140. DOI: 10.4103/EUS-D-21-00188.


Post-ERCP Pancreatitis: Prevention, Diagnosis and Management.

Cahyadi O, Tehami N, de-Madaria E, Siau K Medicina (Kaunas). 2022; 58(9).

PMID: 36143938 PMC: 9502657. DOI: 10.3390/medicina58091261.


Clinical Evaluation of a Newly Developed Guidewire for Pancreatobiliary Endoscopy.

Ishii S, Fujisawa T, Isayama H, Asahara S, Ogiwara S, Okubo H J Clin Med. 2020; 9(12).

PMID: 33339093 PMC: 7765498. DOI: 10.3390/jcm9124059.


References
1.
Kawakami H, Kuwatani M, Etoh K, Haba S, Yamato H, Shinada K . Endoscopic retrograde cholangiography versus peroral cholangioscopy to evaluate intraepithelial tumor spread in biliary cancer. Endoscopy. 2009; 41(11):959-64. DOI: 10.1055/s-0029-1215178. View

2.
Osanai M, Maguchi H, Takahashi K, Katanuma A, Yane K, Kaneko M . Safety and long-term outcomes of endoscopic papillary balloon dilation in children with bile duct stones. Gastrointest Endosc. 2011; 73(3):619-23. DOI: 10.1016/j.gie.2010.10.051. View

3.
Kawamoto H, Tsutsumi K, Harada R, Fujii M, Kato H, Hirao K . Endoscopic deployment of multiple JOSTENT SelfX is effective and safe in treatment of malignant hilar biliary strictures. Clin Gastroenterol Hepatol. 2008; 6(4):401-8. DOI: 10.1016/j.cgh.2007.12.036. View

4.
Ichiya T, Maguchi H, Takahashi K, Katanuma A, Osanai M, Kin T . Endoscopic management of laparoscopic cholecystectomy-associated bile duct injuries. J Hepatobiliary Pancreat Sci. 2010; 18(1):81-6. DOI: 10.1007/s00534-010-0315-z. View

5.
Kawakami H, Kuwatani M, Kudo T, Ehira N, Yamato H, Asaka M . Portobiliary fistula: unusual complication of wire-guided cannulation during endoscopic retrograde cholangiopancreatography. Endoscopy. 2011; 43 Suppl 2 UCTN:E98-9. DOI: 10.1055/s-0030-1256150. View